Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each Subcutaneous doses are much smaller than oral doses because of injection volume limits and because direct subQ absorption skips the gut
adding 50mL of deprotection reagent to remove Fmoc for 30 minutes at the temperature of not more than 20 , adding 50mL of DMF to wash for multiple times, and obtaining positive indene detection result
At Real Peptides, we understand the importance of precision
doi: 10.5681/apb.2013.004
To align with FDA and FTC guidelines, please note: Peptides do not diagnose, treat, cure, or prevent disease
Assessing brain function in stressed healthy individuals following the use of a combination of green tea, Rhodiola, magnesium, and B vitamins: An fMRI study
